Department of Pharmacy, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
BMC Neurol. 2020 Apr 14;20(1):134. doi: 10.1186/s12883-020-01720-5.
For acute ischemic stroke (AIS) patient receiving mechanical thrombectomy (MT), renal dysfunction was an independent risk factor of contrast-induced nephropathy which may affect clinical outcomes. However, the influence of renal function on stroke outcomes is still controversial. Thus, we aim to investigate the association between renal function and outcomes of AIS patients receiving MT.
All consecutive stroke patients receiving MT were included in a prospective stroke registry in China from April 2015 to February 2019. Estimated glomerular filtration rate (eGFR) was measured on admission and categorized into G1 (≥ 90 ml/min/1.73 m), G2 (60-89 ml/min/1.73 m), G3a (45-59 ml/min/1.73 m) and G3b-5 (≤44 ml/min/1.73 m). Multivariable logistic regression analysis was performed to evaluate the association between eGFR and recanalization rate (thrombolysis in cerebral infarction scale 2b-3), symptomatic intracranial hemorrhage (sICH), death in hospital, death at 3 months and poor functional outcome (modified Rankin Scale 3-6 at 3 months).
A total of 373 patients were included in the study. Of them, 130 (34.9%) patients were in the eGFR group G1, 170 (45.6%) in G2, 46 (12.3%) in G3a, 27 (7.2%) in G3b-5. In multivariable logistic regression analysis, reduced eGFR was associated with increased risk of sICH (G3a, p = 0.016) and 3-month death (G3b-5, p = 0.025). However, no significant effects were observed between reduced eGFR and the risk of recanalization rate (p = 0.855), death in hospital (p = 0.970), and poor functional outcome (p = 0.644).
For AIS patients underwent MT, reduced eGFR was associated with increased risk of sICH and 3-month death. However, there were no appreciable effects of reduced eGFR on recanalization rate, death in hospital and 3-month functional outcome.
对于接受机械取栓(MT)的急性缺血性脑卒中(AIS)患者,肾功能障碍是对比剂肾病的独立危险因素,可能会影响临床结局。然而,肾功能对脑卒中结局的影响仍存在争议。因此,我们旨在研究肾功能与接受 MT 的 AIS 患者结局之间的关系。
本研究纳入了 2015 年 4 月至 2019 年 2 月在中国进行的一项前瞻性脑卒中登记研究中的所有连续接受 MT 的脑卒中患者。入院时测量估算肾小球滤过率(eGFR),并分为 G1(≥90 ml/min/1.73 m)、G2(60-89 ml/min/1.73 m)、G3a(45-59 ml/min/1.73 m)和 G3b-5(≤44 ml/min/1.73 m)。采用多变量 logistic 回归分析评估 eGFR 与再通率(脑梗死溶栓量表 2b-3)、症状性颅内出血(sICH)、住院期间死亡、3 个月时死亡和不良功能结局(3 个月时改良 Rankin 量表 3-6)之间的关系。
本研究共纳入 373 例患者。其中,130 例(34.9%)患者 eGFR 为 G1 组,170 例(45.6%)为 G2 组,46 例(12.3%)为 G3a 组,27 例(7.2%)为 G3b-5 组。多变量 logistic 回归分析显示,eGFR 降低与 sICH 风险增加(G3a,p=0.016)和 3 个月时死亡(G3b-5,p=0.025)相关。然而,eGFR 降低与再通率(p=0.855)、住院期间死亡(p=0.970)和 3 个月时不良功能结局(p=0.644)之间无显著相关性。
对于接受 MT 的 AIS 患者,eGFR 降低与 sICH 和 3 个月时死亡风险增加相关。然而,eGFR 降低对再通率、住院期间死亡和 3 个月时的功能结局无明显影响。